Literature DB >> 23684574

Midazolam provides cytoprotective effect during corticosterone-induced damages in rat astrocytes by stimulating steroidogenesis.

Wen-Zhi Guo1, Yu-Liang Miao, Li-Na An, Xiao-Yun Wang, Ning-Ling Pan, Ya-Qun Ma, Hong-Xia Chen, Nan Zhao, Hong Zhang, Yun-Feng Li, Wei-Dong Mi.   

Abstract

Midazolam is a benzodiazepine derivative drug that has powerful anxiolytic, amnestic, hypnotic, and sedative properties. The cytoprotective effect of midazolam on brain astrocytes is poorly understood. This study aimed to investigate the cytoprotective effect of midazolam on astrocytes exposed to corticosterone, a stress-produced glucocorticoid. We found that midazolam stimulated pregnenolone and progesterone secretion in astrocytes in a dose-dependent manner. Midazolam protected astrocytes from corticosterone-induced damages in a dose-dependent manner. In addition, we demonstrated that progesterone reduced corticosterone-induced damages. Finally, we applied trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, to inhibit pregnenolone metabolism and found that pretreatment with trilostane significantly inhibited the cytoprotective effect of midazolam on corticosterone-induced cytotoxicity in rat astrocytes in a dose-dependent manner. Taken together, these results demonstrate that midazolam has cytoprotective effect on astrocytes. This is, at least partially, derived from midazolam-induced steroidogenesis including progesterone and downstream products in astrocytes. Our data provide new insights into the cytoprotective effect of midazolam.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684574     DOI: 10.1016/j.neulet.2013.05.014

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.

Authors:  Martina Santarsieri; Christian Niyonkuru; Emily H McCullough; Julie A Dobos; C Edward Dixon; Sarah L Berga; Amy K Wagner
Journal:  J Neurotrauma       Date:  2014-02-06       Impact factor: 5.269

2.  Pretreatment but not subsequent coincubation with midazolam reduces the cytotoxicity of temozolomide in neuroblastoma cells.

Authors:  Sebastian Braun; Inge Bauer; Benedikt Pannen; Robert Werdehausen
Journal:  BMC Anesthesiol       Date:  2015-10-17       Impact factor: 2.217

3.  Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.

Authors:  Jorge Miguel Amaya; Ernst Suidgeest; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Guilhem Pagès; Cécile Keller; Louise van der Weerd; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

4.  A Comparison of Hematological, Immunological, and Stress Responses to Capture and Transport in Wild White Rhinoceros Bulls (Ceratotherium simum simum) Supplemented With Azaperone or Midazolam.

Authors:  Friederike Pohlin; Emma H Hooijberg; Peter Buss; Nikolaus Huber; Francois P Viljoen; Dee Blackhurst; Leith C R Meyer
Journal:  Front Vet Sci       Date:  2020-10-20

5.  Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition.

Authors:  Hsin-Ling Lu; King-Chuen Wu; Char-Wen Chen; Hong-Kai Weng; Bu-Miin Huang; Ting-Yu Lin; Ming-Hsin Liu; Edmund-Cheung So; Ruey-Mo Lin; Yang-Kao Wang
Journal:  Life (Basel)       Date:  2021-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.